Sheldon Preskorn, MD, Senior Vice President of Neuroscience, presented “10 Lessons Learned Over 40 Years of Drug Development Research in Psychiatry” at the 2024 CNS Summit. Dr. Preskorn provided strategies for enhancing clinical trial design, minimizing patient...
Lynn Webster, MD, Executive Vice President of Scientific Affairs, recently presented his poster titled “A Review of the Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride...
Our Executive Vice President of Scientific Affairs, Dr. Lynn Webster, has released a co-authored review on opioid abuse-deterrent formulations (ADFs). This comprehensive analysis delves into the effectiveness of ADFs in reducing misuse and abuse while highlighting the...
Recent Comments